ArticleFrontiers in oncology2022

PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer.

Liping Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.